Fycompa .5 mg/mL
perampanel · SUSPENSION · Catalyst Pharmaceuticals, Inc.
No Recall History
Plain English
Fycompa is a suspension containing perampanel at .5 mg/mL, taken oral. Manufactured by Catalyst Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Fycompa
- Generic Name
- perampanel
- NDC Code (Product)
69616-290- Manufacturer
- Catalyst Pharmaceuticals, Inc.
- Strength
- .5 mg/mL
- Dosage Form
- SUSPENSION
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule III (Controlled)
- Application #
- NDA208277
- Drug Class
- Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]
- Marketing Start
- 01/02/2024
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
seizure1,121 reports
drug ineffective1,072 reports
off label use772 reports
somnolence500 reports
aggression491 reports
dizziness387 reports
epilepsy340 reports
multiple-drug resistance326 reports
status epilepticus325 reports
drug interaction323 reports
Frequently Asked Questions
What is Fycompa used for?
Fycompa contains perampanel. It is a suspension taken oral. Consult your doctor for specific uses.
Is Fycompa a controlled substance?
Yes, Fycompa is classified as CIII under the DEA Controlled Substances Act.
What is the generic name for Fycompa?
The generic name for Fycompa is perampanel. There are 6 other brand versions of perampanel.
What is the NDC code for Fycompa .5 mg/mL?
The NDC (National Drug Code) for Fycompa .5 mg/mL is 69616-290, listed by Catalyst Pharmaceuticals, Inc..